Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMUS-7: Ticagrelor Maintenance Dosing in Diabetes
NCT04484259Phase 4Completed
- Sponsor
- University of Florida
- Start
- Mar 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by University of Florida. Started Mar 2021; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04484259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04484259.